One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, organ-on-a-chip–based drug discovery and development platforms, ...

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

Explore the link between cancer and bacterial relapse in light of new research on biological noise and therapy strategies.

IonQ's next-generation Tempo 100 quantum system will help create the first instance of hybrid quantum-classical onsite ...

The attack on Venezuela and the capture of President Nicolás Maduro herald the decoupling of Trump’s United States from the ...

A FLOP is a single floating‑point operation, meaning one arithmetic calculation (add, subtract, multiply, or divide) on ...